Gulf International Bank (Uk) LTD Nektar Therapeutics Transaction History

Gulf International Bank (Uk) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$15.87 - $23.12 $613,200 - $893,333	-38,639 Closed	0 $0
Q4 2018 Jan 08, 2019	SELL	$30.43 - $56.65 $502,095 - $934,725	-16,500 Reduced 29.92%	38,639 $1.27 Million
Q3 2018 Nov 05, 2018	BUY	$46.46 - $68.49 $102,212 - $150,678	2,200 Added 4.16%	55,139 $3.36 Million
Q2 2018 Jul 05, 2018	BUY	$46.25 - $104.45 $2.45 Million - $5.53 Million	52,939 New	52,939 $2.59 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.